Viktoria Mühlbauer1, Dhayana Dallmeier, Simone Brefka, Claudia Bollig, Sebastian Voigt-Radloff, Michael Denkinger. 1. Joint first authors; Department of Geriatrics, University of Ulm and Geriatric Center Ulm/Alb-Donau, Agaplesion Bethesda Hospital; Institute for Evidence in Medicine (for the Cochrane Germany Foundation), Faculty of Medicine, University Hospital Freiburg; Freiburg Center for Geriatrics and Gerontology, Faculty of Medicine, University Hospital Freiburg.
Abstract
BACKGROUND: It is debated whether the treatment goals and decision-making algorithms for elderly patients with hypertension should be the same as those for younger patients. The American and European guidelines leave decisions about antihypertensive treatment in frail, institutionalized patients up to the treating physician. We therefore systematically searched the literature for publications on the phamacotherapy of arterial hypertension in frail patients. METHODS: The MEDLINE, Embase, and Central databases were systematically searched for randomized, controlled trials (RCTs) and non-randomized studies, including observational studies, on the pharmacotherapy of arterial hypertension in elderly patients since the introduction of the concept of frailty, published over the period 1992-2017. RESULTS: Out of 19 282 citations for randomized, controlled trials and 5659 for non-randomized trials and observational studies, four RCTs and three observational studies were included in the further analysis. The included RCTs showed a trend to- wards a benefit from pharmacotherapy of hypertension in frail patients with respect to mortality, cardiovascular disease, functional status, and quality of life. On the other hand, some of the observational studies indicated a lower rate of falls and lower mortality among patients who received no antihypertensive treatment. CONCLUSION: In view of the conflicting findings of RCTs and non-randomized studies, the lower representation of frail subjects in RCTs, and the high risk of bias in non- randomized studies, the findings of the studies included in this review do not enable the formulation of any strictly evidence-based treatment recommendations. As a rule of thumb, the authors propose that a target systolic blood pressure of <150 mmHg should be aimed at in patients whose gait speed is less than 0.8 m/s, while a target range of 130-139 mmHg can be set for patients over age 80 who are no more than mildly frail.
BACKGROUND: It is debated whether the treatment goals and decision-making algorithms for elderly patients with hypertension should be the same as those for younger patients. The American and European guidelines leave decisions about antihypertensive treatment in frail, institutionalized patients up to the treating physician. We therefore systematically searched the literature for publications on the phamacotherapy of arterial hypertension in frail patients. METHODS: The MEDLINE, Embase, and Central databases were systematically searched for randomized, controlled trials (RCTs) and non-randomized studies, including observational studies, on the pharmacotherapy of arterial hypertension in elderly patients since the introduction of the concept of frailty, published over the period 1992-2017. RESULTS: Out of 19 282 citations for randomized, controlled trials and 5659 for non-randomized trials and observational studies, four RCTs and three observational studies were included in the further analysis. The included RCTs showed a trend to- wards a benefit from pharmacotherapy of hypertension in frail patients with respect to mortality, cardiovascular disease, functional status, and quality of life. On the other hand, some of the observational studies indicated a lower rate of falls and lower mortality among patients who received no antihypertensive treatment. CONCLUSION: In view of the conflicting findings of RCTs and non-randomized studies, the lower representation of frail subjects in RCTs, and the high risk of bias in non- randomized studies, the findings of the studies included in this review do not enable the formulation of any strictly evidence-based treatment recommendations. As a rule of thumb, the authors propose that a target systolic blood pressure of <150 mmHg should be aimed at in patients whose gait speed is less than 0.8 m/s, while a target range of 130-139 mmHg can be set for patients over age 80 who are no more than mildly frail.
Authors: Mary E Tinetti; Ling Han; David S H Lee; Gail J McAvay; Peter Peduzzi; Cary P Gross; Bingqing Zhou; Haiqun Lin Journal: JAMA Intern Med Date: 2014-04 Impact factor: 21.873
Authors: Paul K Whelton; Robert M Carey; Wilbert S Aronow; Donald E Casey; Karen J Collins; Cheryl Dennison Himmelfarb; Sondra M DePalma; Samuel Gidding; Kenneth A Jamerson; Daniel W Jones; Eric J MacLaughlin; Paul Muntner; Bruce Ovbiagele; Sidney C Smith; Crystal C Spencer; Randall S Stafford; Sandra J Taler; Randal J Thomas; Kim A Williams; Jeff D Williamson; Jackson T Wright Journal: Circulation Date: 2018-10-23 Impact factor: 29.690
Authors: Simone Brefka; Dhayana Dallmeier; Viktoria Mühlbauer; Christine A F von Arnim; Claudia Bollig; Graziano Onder; Mirko Petrovic; Carlos Schönfeldt-Lecuona; Moritz Seibert; Gabriel Torbahn; Sebastian Voigt-Radloff; Walter E Haefeli; Jürgen M Bauer; Michael D Denkinger Journal: J Am Med Dir Assoc Date: 2019-01-09 Impact factor: 4.669
Authors: Michelle C Odden; Carmen A Peralta; Dan R Berlowitz; Karen C Johnson; Jeffrey Whittle; Dalane W Kitzman; Srinivasan Beddhu; John W Nord; Vasilios Papademetriou; Jeff D Williamson; Nicholas M Pajewski Journal: JAMA Intern Med Date: 2017-04-01 Impact factor: 21.873
Authors: Nigel S Beckett; Ruth Peters; Astrid E Fletcher; Jan A Staessen; Lisheng Liu; Dan Dumitrascu; Vassil Stoyanovsky; Riitta L Antikainen; Yuri Nikitin; Craig Anderson; Alli Belhani; Françoise Forette; Chakravarthi Rajkumar; Lutgarde Thijs; Winston Banya; Christopher J Bulpitt Journal: N Engl J Med Date: 2008-03-31 Impact factor: 91.245
Authors: Claudia Bollig; Gabriel Torbahn; Jürgen Bauer; Simone Brefka; Dhayana Dallmeier; Michael Denkinger; Annette Eidam; Stefan Klöppel; Andrej Zeyfang; Sebastian Voigt-Radloff Journal: Z Gerontol Geriatr Date: 2020-04-17 Impact factor: 1.281
Authors: Anne Göhner; Elena Dreher; Felix Kentischer; Christoph Maurer; Erick Farin-Glattacker; Rieka von der Wart; Boris A Brühmann; Andy Maun; Vitalii Minin; Claudia Salm; Alexander Ritzi; Mario Sofroniou; Sebastian Voigt-Radloff Journal: BMC Geriatr Date: 2022-09-15 Impact factor: 4.070